Xu is a postdoctoral fellow in Dan Yang's research group at the School of Life Sciences. She has long been engaged in the research and development of drugs and novel biomarkers of cardiovascular and metabolic diseases. Metabolic diseases, such as obesity and diabetes, affect a wide range of patients. China has more than 140 million diabetics, the world's largest number of people suffering from the disease. Early diagnosis and treatment of such diseases remains difficult due to the complex pathogenesis. Xu hopes that through her research, small molecular probes can be used to find new targets for metabolic diseases and overcome the challenges in early diagnosis and the many side effects of long-term medication.
Xu is also a winner of the Westlake Outstanding Postdoctoral Women award. This video is part of a special series called ‘Women in Science’ to celebrate the important role women have played and continue to play in the pursuit of science and technology. Read more of the interview here:
[ Ссылка ]
Follow us:
Twitter: [ Ссылка ]
Facebook: [ Ссылка ]
Instagram: [ Ссылка ]
LinkedIn: [ Ссылка ]
Visit us: [ Ссылка ]
